Anti-Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy

Mesenchymal stem cells (MSCs) are very attractive candidates in cell-based strategies that target inflammatory diseases. Preclinical animal studies and many clinical trials have demonstrated that human MSCs can be safely administered and that they modify the inflammatory process in the targeted inju...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Waterman, Ruth S., Morgenweck, Jenny, Nossaman, Bobby D., Scandurro, Anna E., Scandurro, Sophia A., Betancourt, Aline M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: AlphaMed Press 2012
Θέματα:
Enabling Technologies for Cell-Based Clinical Translation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659725/
https://ncbi.nlm.nih.gov/pubmed/23197860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2012-0025
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια